Attached files
| file | filename |
|---|---|
| EX-1.1 - FORM OF PLACEMENT AGENCY AGREEMENT BETWEEN THE COMPANY AND MAXIM GROUP LLC. - SOLIGENIX, INC. | fs12013a2ex1i_soligenix.htm |
| EX-23.1 - CONSENT OF EISNERAMPER LLP. - SOLIGENIX, INC. | fs12013a2ex23i_soligenix.htm |
| EX-10.39 - FORM OF WARRANT TO PLACEMENT AGENT. - SOLIGENIX, INC. | fs12013a2ex10xxxix_soligenix.htm |
| EX-10.38 - FORM OF WARRANT TO INVESTORS. - SOLIGENIX, INC. | fs12013a2ex10xxxviii_soligen.htm |
| S-1/A - REGISTRATION STATEMENT - SOLIGENIX, INC. | fs12013a2_soligenix.htm |
| EX-10.37 - FORM OF SECURITIES PURCHASE AGREEMENT, AMONG THE COMPANY AND CERTAIN INVESTORS. - SOLIGENIX, INC. | fs12013a2ex10xxxvii_soligen.htm |
EXHIBIT 21.1
SUBSIDIARIES OF SOLIGENIX, INC.
The following represents a list of Soligenix, Inc.’s subsidiaries:
|
Name
|
Ownership
|
State of Incorporation | ||||||
|
Enteron Pharmaceuticals, Inc.
|
100.00
|
%
|
Delaware
|
|||||
|
Orasomal Technologies Inc.
|
75.30
|
%
|
Delaware
|
|||||
|
BioDefense Corp.
|
100.00
|
%
|
Delaware
|
|||||
|
Soligenix BioPharma Canada Incorporated
|
100.00
|
%
|
Canada
|
|||||
|
Soligenix UK Limited
|
100.00
|
%
|
United Kingdom
|
|||||